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The production of virus-like particles (VLPs) constitutes a relevant and safe model to study molecular
determinants of virion egress. The minimal requirement for the assembly of VLPs for the coronavirus
responsible for severe acute respiratory syndrome in humans (SARS-CoV) is still controversial. Recent studies
have shown that SARS-CoV VLP formation depends on either M and E proteins or M and N proteins. Here
we show that both E and N proteins must be coexpressed with M protein for the efficient production and release
of VLPs by transfected Vero E6 cells. This suggests that the mechanism of SARS-CoV assembly differs from
that of other studied coronaviruses, which only require M and E proteins for VLP formation. When coex-
pressed, the native envelope trimeric S glycoprotein is incorporated onto VLPs. Interestingly, when a fluores-
cent protein tag is added to the C-terminal end of N or S protein, but not M protein, the chimeric viral proteins
can be assembled within VLPs and allow visualization of VLP production and trafficking in living cells by
state-of-the-art imaging technologies. Fluorescent VLPs will be used further to investigate the role of cellular
machineries during SARS-CoV egress.
Coronaviruses are positive-sense RNA enveloped viruses
that belong to the Coronaviridae family in the Nidovirales or-
der. These viruses are found in a wide variety of animals and
can cause respiratory and enteric disorders of diverse severity
(11, 18). In the past 5 years, several human and animal coro-
naviruses have been discovered, including the highly patho-
genic virus responsible for the severe acute respiratory syn-
drome (SARS-CoV) (34, 58, 60, 64, 68, 69). Coronavirus
particles consist of a helical nucleocapsid structure, formed by
the association between nucleocapsid (N) phosphoproteins
and the viral genomic RNA, which is surrounded by a lipid
bilayer where three or four types of structural proteins are
inserted: the spike (S), the membrane (M), and the envelope
(E) proteins and, for some coronaviruses only, the hemagglu-
tinin-esterase (HE) protein (for a review, see reference 14).
Once sufficient amounts of new genomic RNA and structural
proteins have been produced, assembly of particles occurs.
Assembly and release of virions are the last stages of the virus
life cycle.
The triple-spanning membrane glycoprotein M drives the
assembly of coronavirus, which bud into the lumen of the endo-
plasmic reticulum-Golgi intermediary compartment (ERGIC)
(32, 33, 62, 63). M is the most abundant envelope protein that
sorts viral components to be incorporated into virions. M oligo-
merization, mainly driven by its transmembrane domain, is
believed to allow the formation of a lattice of M proteins at
ERGIC membranes (16, 41). S and E membrane proteins are
integrated into the lattice through lateral interactions with M,
whereas N and viral RNA interact with M C-terminal domain,
which is exposed to the cytosol (4, 8, 15, 19, 30, 36, 48, 54, 55).
The coronavirus S protein, responsible for receptor binding
and membrane fusion, does not seem to have any major role in
coronavirus assembly. Recent studies show that E is a viro-
porin that forms ion channels (46, 66, 67). Despite its minor
incorporation into virion particles (7, 22, 40), the small E
protein plays an important but not fully understood role in
virus morphogenesis and budding (20, 35, 70). Studies per-
formed on coronaviruses, including the SARS-CoV, demon-
strate that depletion of the E gene from coronavirus genome
strongly diminish virus growth and particle formation (9, 12,
35, 37, 57). The N protein self-associates and encapsidates the
RNA genome for incorporation into budding virions through
interactions with the M protein independently of E and S
proteins (24, 52, 53, 61). For SARS-CoV, the interaction of N
with M was described to be independent of viral RNA (25, 45).
Work on mouse hepatitis virus (MHV), bovine coronavirus,
infectious bronchitis virus, and transmissible gastroenteritis vi-
rus has established that E and M proteins are necessary and
sufficient for assembly of virus-like particles (VLPs), which
share size and morphological features with real viruses (1, 2, 7,
8, 38, 65). Nevertheless, the minimal requirement for assembly
of SARS-CoV VLPs is still controversial. Y. Huang et al.
described formation of VLPs in transfected human 293 renal
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epithelial cells that only required coexpression of the M and N
viral proteins (29). On the contrary, other studies described
that coexpressed M and E proteins were sufficient for release
of sedimentable particles from transfected mammalian cells
(27) or insect cells, using a baculovirus expression system (26,
50). A few groups have proposed immunization with SARS-
CoV VLPs as an effective vaccine strategy. VLPs produced in
insect cells or chimeric MHV/SARS-CoV VLPs produced in
mammalian cells were used in these studies (42, 44).
Our objective was to delineate the molecular mechanisms
that regulate SARS-CoV egress in mammalian cells. Here we
demonstrate that whereas VLPs could hardly be recovered
from culture medium of cells coexpressing combinations of M
and E or M and N proteins, coexpression of both SARS-CoV
E and N with M allowed the release of significant levels of
VLPs within 1 day. When coexpressed, the trimeric S protein
was found in VLPs. Therefore, in apparent contrast to other
coronaviruses, SARS-CoV egress strongly depends on three
structural proteins: M, E, and N. The addition of fluorescent
tags to viral structural proteins allowed us to visualize the
egress of fluorescent VLPs in living cells. Monitoring of VLP
egress in living cells will be a powerful new tool for studying the
involvement of viral and cellular factors during the late stages
of the SARS-CoV life cycle.
MATERIALS AND METHODS
Cells and culture conditions. The Vero E6 African green Monkey kidney cell
line was cultured in Dulbecco modified Eagle medium (DMEM) supplemented
with 10% heat-inactivated fetal calf serum, 100 U of penicillin, and 100 g of
streptomycin per ml at 37°C with 5% CO2.
Plasmid constructions. cDNAs coding for the SARS-CoV M, E, S, and N
structural proteins were codon optimized for mammalian cells and synthesized
by GeneArt (Regensburg, Germany). The M cDNA was amplified by PCR and
subcloned into the pIRES plasmid vector (BD Biosciences, San Jose, CA) be-
tween the NheI and EcoR I restriction sites of the upstream multiple cloning site.
The E cDNA was amplified by PCR and inserted either into the pcDNA3.1
plasmid vector between the KpnI and NotI restriction sites or into the pIRES
plasmid vector between the SalI and NotI restriction sites of the downstream
multiple cloning site. The S cDNA was amplified by PCR and inserted either into
the pcDNA3.1 plasmid vector between the NheI and ApaI restriction sites. The
pcDNA-Nflag plasmid was constructed from the original pCRScript-Nflag (pro-
duced by GeneArt, Regensburg, Germany) using the KpnI and XhoI restriction
sites. The Flag tag was in fusion with the 3 end of N cDNA and separated from
N cDNA by six nucleotides encoding two glycine residues. The cDNAs coding for
the enhanced yellow (eYFP), cyan (eCFP), and green (eGFP) fluorescent pro-
teins and the monomeric red fluorescent protein (mRFP1) (5) were amplified by
PCR from plasmids purchased from Clontech Laboratories (Takara Bio, Shiga,
Japan) and subcloned into pcDNA3.1 or pIRES vectors. The S, N, or M cDNAs
were then inserted 5 to the fluorescent protein cDNAs using the ClaI and ApaI
sites (S and N) or the XhoI and MluI (M) restriction sites. The two fused cDNAs
were separated by two codons encoding glycines.
Antibodies. The M and E proteins were detected with rabbit polyclonal anti-
bodies raised against the C-terminal extremity of each protein. The rabbit poly-
clonal antibody against the M C-terminal domain was purchased from ProSci,
Inc. (Poway, CA). The rabbit polyclonal antibody against the E protein was
produced by Nicolas Escriou (Institut Pasteur, Paris, France) using a C-terminal
peptide. The Flag tag was detected with the mouse monoclonal immunoglobulin
G1 M2 antibody purchased from Sigma-Aldrich. The mouse polyclonal antibody
against the S protein was obtained by immunizing mice with purified S trimers
expressed in mammalian cells as described previously (31). The mouse mono-
clonal antibody against the N protein was a generous gift from K. H. Chan
(Department of Microbiology, University of Hong Kong) and produced as de-
scribed previously (56).
Transient transfections and production of SARS-CoV VLPs. A total of 8 105
cells were plated in 75-cm2 dishes, incubated overnight, and transfected with
plasmid constructs using a FuGENE 6 transfection reagent (Roche, Basel, Swit-
zerland), according to the manufacturer’s instructions. Briefly, 54 l of FuGENE
6 transfection reagent was mixed with DMEM, followed by incubation for 5 min,
and then 6 g of each plasmid was added. The FuGENE 6-plasmid mixture was
incubated for 30 min at room temperature. Cell medium was discarded and
replaced with 3 ml of warm DMEM. The FuGENE 6-plasmid mixture was added
to the cells. After 3 h of incubation at 37°C, the medium containing the trans-
fection mixture was discarded, and 10 ml of fresh medium was added. Cells were
incubated for 21 or 45 h.
Purification of SARS-CoV VLPs. At 24 or 48 h posttransfection, cell medium
was collected and cleared by centrifugation at low speed (1,000  g for 10 min)
to pull down cell debris. After passage through 0.45-m-pore-size filter, cleared
cell medium was then loaded on top of 20% sucrose cushions and ultracentri-
fuged for 3 h at 28,000 rpm using a SW41 rotor (Belkman Coulter, Inc., Fuller-
ton, CA). VLP-containing pellets were resuspended in TNE buffer (50 mM
Tris-HCl, 100 mM NaCl, 0.5 mM EDTA, [pH 7.4]).
Western blot analysis of VLPs and cell lysates. For Western blot analysis of
purified VLPs, 15 l of resuspended pellets from ultracentrifuged culture me-
dium was mixed with 5 l of lithium dodecyl sulfate-containing loading buffer
and loaded onto 4 to 12% polyacrylamide gels (NuPAGE Novex Bis-Tris Mini
Gels; Invitrogen, Carlsbad, CA). Electrophoresis was performed with the
NuPAGE morpholinepropanesulfonic acid sodium dodecyl sulfate (SDS) run-
ning buffer from the same manufacturer. Alternatively, resuspended pellets from
48-h time points were loaded on top of 20 to 60% sucrose gradients and ultra-
centrifuged for 3.5 h at 26,700 rpm (27). Twenty fractions were collected and
analyzed by Western blotting. For Western blot analysis of cell lysates, cells were
washed twice with 1 phosphate-buffered saline (PBS) at 24 or 48 h posttrans-
fection and lysed in lysis buffer containing 1% Triton X-100, 150 mM NaCl, 20
mM Tris-HCl (pH 7.5), and 1 mM EDTA for 15 min on ice with frequent
vortexing. The lysates were then cleared by centrifugation at 16,100  g for 15
min at 4°C and analyzed by Western blotting. Next, 15 l of each lysate was
mixed with 5 l of lithium dodecyl sulfate loading buffer and loaded on polyac-
rylamide gels. For detection of E but not S, samples were treated with dithio-
threitol and heated at 95°C for 5 min before migration on polyacrylamide gels.
To detect both E and trimers of S from same preparations, samples were split
and either treated or not treated before loading of two separate gels for E and
S detection, respectively. The results for M and Nflag were similar with or
without treatment.
Electron microscopy. For transmission electron microscopy experiments,
transfected cells were harvested at 24 and 48 h posttransfection. Cells were
detached using 10 mM EDTA, fixed in 2.5% glutaraldehyde in cacodylate buffer,
and postfixed with 1% osmium tetroxide (OsO4) in cacodylate buffer for 1 h at
room temperature. The cells were then embedded in 2% agarose to form cell
blocks that were dehydrated in graded series of ethanol and embedded in epoxy
resin. Ultrathin sections were stained for 45 min with 2% aqueous uranyl acetate
and for 30 min with Reynolds lead citrate. For analysis of secreted VLPs, the
VLPs were purified from the cell medium by ultracentrifugation on a 20%
sucrose cushion and separated on a 20 to 60% discontinuous sucrose gradient,
and fraction 10 was collected and then concentrated by ultracentrifugation in
TNE buffer (pH 7.4) for 1 h at 28,000 rpm. Next, 5 l of the VLP suspension,
mixed with an equal volume of negative stain (2% aqueous uranyl acetate and
2% phosphotungstate solution [pH 7.0]), was placed onto a Formvar-carbon-
coated copper grid for 2 min, and the excess suspension was drained. The grids
were viewed and photographed with a Philip CM100 electron microscope at
80 kV.
Fluorescence microscopy. For fluorescence microscopy on fixed cells, Vero E6
cells were grown on glass coverslips, transfected, and analyzed at 24 h posttrans-
fection. Cells were washed with PBS, nuclei were stained with DAPI (4,6-
diamidino-2-phenylindole), and coverslips were mounted on glass slides for anal-
ysis. Fixed cells were visualized under an AxioObserver Z1 inverted motorized
fluorescence microscope using the ApoTome module and piloted through the
Axiovision 4.6 software, and images were acquired through an MRm AxioCam
high-resolution charge-coupled device camera (Carl Zeiss, Germany). For fluo-
rescence microscopy on live cells, Vero E6 cells were grown in a glass-bottom
culture dish (MatTech), transfected, and analyzed at 24 h posttransfection. The
cells were washed, and the medium was changed to Hanks balanced salt solution-
OptiMEM prewarmed culture medium. Wide-field image acquisitions of live
cells were obtained using the system described above. Confocal acquisitions of
live cells were acquired at the Hong Kong University Core Imaging Facility using
an AxioObserver Z1 inverted motorized fluorescence microscope equipped with
a spinning disc confocal imaging system (UltraVIEW ERS; Perkin-Elmer, Shel-
ton, CT). For brefeldin A (BFA) treatment, cells were incubated with 6 g per
ml of BFA for the indicated times. To release the BFA effect, the cells were
washed three times in 1 PBS and reincubated in normal medium for the
indicated times.
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RESULTS
Efficient production and release of SARS-CoV VLPs are
driven by coexpression of M, N, and E structural proteins. To
determine the optimal conditions for efficient SARS-CoV VLP
production, we chose to coexpress different combinations of
structural proteins in the Vero E6 African green monkey cell
line, which is permissive to SARS-CoV replication (34).
cDNAs encoding SARS-CoV structural proteins M, E, and N
were codon optimized for expression in mammalian cells. Un-
derstanding the importance of maintaining a low E/M ratio in
transfected cells to ensure low incorporation of E into VLPs
and to prevent the potential formation of E-containing vesi-
cles, we reasoned that the use of the pIRES bicistronic plasmid
should be appropriate. This plasmid presents the double ad-
vantage to ensure coexpression of both cDNAs in transfected
cell and allows a reduced rate of translation of the downstream
gene by utilizing a partially disabled internal ribosome entry
site (IRES) sequence. We therefore subcloned M upstream of
E cDNA in the pIRES vector. N was expressed from a pcDNA
plasmid with a C-terminal Flag tag. Vero E6 cells were either
not transfected or transfected with pcDNA-E, pIRES-M, or
pIRES-M-E alone, pIRES-M plus pcDNA-Nflag, and pIRES-
M-E plus pcDNA-Nflag (Fig. 1A). At 24 and 48 h posttrans-
fection, the culture medium and cells were harvested. The
culture medium was subjected to ultracentrifugation on a 20%
sucrose cushion to isolate VLPs, and the SARS-CoV structural
proteins assembled into VLPs were analyzed by Western blot-
ting.
The M protein was readily detected at both 24 and 48 h
posttransfection in lysates from Vero E6 cells transfected with
pIRES-M, pIRES-M-E, pIRES-M plus pcDNA-Nflag, and
pIRES-M-E plus pcDNA-Nflag (Fig. 1A, upper panels). As
described previously, three major forms of M, which corre-
spond to different glycoforms, were detected by SDS-polyacryl-
amide gel electrophoresis: two bands at ca. 18 and 28 kDa and
a smear at higher molecular sizes reflecting heterogeneity of
glycosylation patterns (51). As expected, higher levels of M
were detected in cell lysates at 48 h than at 24 h posttransfec-
tion. Whereas a 10-kDa protein corresponding to E could be
easily detected in cell lysates from cells transfected with
pcDNA-E plasmid, its expression was much lower in cells
transfected with the pIRES-M-E bicistronic vector. The Nflag
protein was found in cell lysates from both pIRES-M plus
pcDNA-Nflag and pIRES-M-E plus pcDNA-Nflag transfected
cells at similar levels. A major band corresponding to a protein
with an apparent molecular size of 45 kDa was detected.
Strikingly, the efficacy of VLP production was dramatically
affected by the combination of viral proteins coexpressed (Fig.
1A, lower panels). Although M was not detected in ultracen-
trifuged culture medium from pIRES-M, pIRES-M-E, or
pIRES-M plus pcDNA-Nflag transfected cells at 24 h post-
transfection, significant levels were found in preparations from
pIRES-M-E plus pcDNA-Nflag transfected cells. Similarly, the
N protein was only detected in ultracentrifuged culture me-
dium from pIRES-M-E plus pcDNA-Nflag transfected cells at
this early time point. Signals for E were below the limit of
detection at 24 h and detectable only at 48 h. Finding low
amounts of E in VLPs is in accordance with the minor pres-
ence of this protein in coronavirus particles, despite its impor-
tant role for virion assembly and budding (9, 20, 37, 57, 65). In
conclusion, only when M, E, and N proteins were coexpressed,
VLPs that contained the M and N proteins could be isolated
from the culture medium at 24 h posttransfection.
At 48 h posttransfection, E was found in ultracentrifuged
culture medium from cells transfected with the pcDNA-E plas-
mid alone. This is in agreement with previously published data
that describe secretion of E proteins independently of other
viral elements (7, 47, 50). At this time point, trace amounts of
M were detected in ultracentrifuged culture medium from
pIRES-M and pIRES-M-E transfected cells, whereas signifi-
cant levels of M and N were found in pIRES-M plus pcDNA-
Nflag ultracentrifuged culture medium. Independent secretion
of SARS-CoV M proteins from Vero E6 cells as well as pro-
duction of M-E VLPs was described by Mortola and Roy (50)
at 4 days posttransfection. The production of SARS-CoV M-N
VLPs has already been reported by Y. Huang et al. in trans-
fected 293 renal epithelial cells at 63 h posttransfection (29).
Very interestingly, in the conditions described here, signifi-
cantly higher levels of M and N proteins were found in purified
VLPs from pIRES-M-E plus pcDNA-Nflag than in those from
pIRES-M plus pcDNA-Nflag transfected cells at 48 h post-
transfection. We were also able to detect E in these conditions,
but not when cells were only transfected with the pIRES-M-E
vector.
In order to verify that inefficacy of production of M-E VLPs
by cells transfected with pIRES-M-E was not due to inefficient
E expression, we performed similar experiments but expressed
E from a pCDNA-E plasmid and analyzed cells and medium at
48 h posttransfection (Fig. 1B). As expected, higher levels of E
were detected in the lysates of cells transfected with pIRES-M
plus pCDNA-E and with pIRES-M plus pCDNA-E plus
pCDNA-Nflag than in the lysates of cells transfected with
pIRES-M-E and with pIRES-M-E plus pCDNA-Nflag, respec-
tively (Fig. 1B, left panel). Nevertheless, neither production of
M-E VLPs nor production of M-E-N VLPs was improved by
an increase in E expression (Fig. 1B, right panel). On the
contrary, production of M-E-N VLPs was enhanced when the
bicistronic vector was used, as indicated by higher levels of
Nflag, M, and E proteins secreted, and the ratio E(medium)/
E(lysate) was significantly higher in these conditions. This re-
sult suggests that expression of E along with M from the
pIRES-M-E bicistronic vector and in combination with N fa-
vors the production of SARS-CoV VLPs.
We then investigated cosedimentation of secreted viral
structural proteins by performing sucrose gradient fraction-
ation on ultracentrifuged cell medium. Cells were either trans-
fected by individual plasmids or combinations of plasmids as
described previously. In this experiment we used the individual
plasmid for E expression to verify the potential presence of
E-containing vesicles in medium when E was expressed at
higher levels. At 48 h posttransfection, cleared cell medium
was ultracentrifuged on 20% sucrose cushion, and pellets were
resuspended in TNE buffer. As controls, viral proteins con-
tained in cell lysates and pellets from ultracentrifuged medium
were analyzed by Western blotting (Fig. 1C, left panel). Pellets
were loaded on top of 20 to 60% discontinuous sucrose gradi-
ents. After another round of ultracentrifugation, 20 fractions
were collected and analyzed by Western blotting (Fig. 1C, right
panels a to e). The results were consistent with the data de-
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scribed in Fig. 1A and B. When M was expressed alone, very
little protein was found in the cell medium, and traces were
detected in fraction 9 (Fig.1Ca). Coexpression with E or Nflag
allowed the secretion of slightly higher levels of M in cell
medium and the detection of M in fractions 7 to 11, with
enrichment in fraction 10 (Fig.1Cc) or 11 (Fig.1Cd), respec-
tively. E protein was not detectable in fractions from the me-
dium of either pCDNA-E or pIRES-M plus pCDNA-E trans-
fected cells (Fig. 1Cb and c). Nflag cosedimented with M when
coexpressed (Fig.1Cd). As expected, greater levels of M, E,
and Nflag proteins were found in the medium from cells ex-
pressing all three viral proteins (Fig.1Ce). M and Nflag were
FIG. 1. Production of SARS-CoV VLPs by transfected Vero E6 cells. (A) Coexpression of M, E, and N is necessary for efficient secretion of
SARS-CoV VLPs by Vero E6 cells at 24 and 48 h posttransfection. Monolayers of Vero E6 cells were transfected with plasmids driving the
expression of the SARS-CoV structural proteins M, E, and Flag-tagged N as specified at the top of each lane. Protein expression in cell lysates
and in VLPs isolated from culture medium was analyzed by Western blotting at 24 and 48 h posttransfection, as indicated below the corresponding
panels. Samples were heat denatured and reduced with dithiothreitol before loading. The M and E proteins were detected with rabbit polyclonal
antibodies produced against the C-terminal extremity of each proteins. The N protein was detected with the M2 monoclonal antibody recognizing
the Flag tag. Blots were exposed for 1 min for signal detection except for the detection of E contained in pellets from ultracentrifuged culture
medium (bottom panels), for which blots were exposed for 10 min. The molecular mass (in kilodaltons) and the migration of protein standards
are shown between the blots. (B) Use of the bicistronic pIRES-M-E vector restrains the E expression level and favors the production of M-E-N
VLPs. Vero E6 cells were transfected with the indicated plasmid combinations, and the cell lysates and medium were analyzed at 48 h
posttransfection as in panel A. To ensure better detection of E, VLPs were concentrated four times more than in panel A. Blots were exposed for
10 s for signal detection except for the detection of E contained in pellets from ultracentrifuged culture medium (right bottom panel), for which
the blot was exposed for 1 min. (C) Secreted viral structural proteins cosediment in sucrose gradient. Three 75-cm2 dishes of Vero E6 cells were
transfected with plasmids driving the expression of SARS-CoV structural proteins M, E, and Flag-tagged N either individually or in combination.
Protein expression in cell lysates and in pellets from culture medium ultracentrifuged on 20% sucrose cushion was controlled by Western blot at
48 h posttransfection (left panel). Resuspended pellets from ultracentrifuged cell medium were then loaded on a 20 to 60% discontinuous sucrose
gradient and subjected to fractionation by ultracentrifugation. Twenty fractions of 600 l were collected (1 to 20, from lightest to heaviest). The
nature of viral proteins associated with each fraction was determined by Western blotting (a to e). Portions (15 l) of samples were heat denatured
and reduced with dithiothreitol before loading. The molecular mass (in kilodaltons) and the migration of protein standards are shown on the right
sides of the blots. Samples from (i) pIRES-M, pIRES-M plus pCDNA-E, and pIRES-M plus pCDNA-E plus pcDNA-Nflag and (ii) pcDNA-E and
pIRES-M plus pcDNA-Nflag were generated in two separate experiments. Ctrl, nontransfected cells; E, pCDNA-E; M, pIRES-M; M-E,
pIRES-M-E; M  Nflag, pIRES-M plus pcDNA-Nflag; M-E  Nflag, pIRES-M-E plus pcDNA-Nflag; M  E, pIRES-M  pcDNA-E; M  E 
Nflag, pIRES-M plus pcDNA-E plus pcDNA-Nflag.
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present in fractions 5 to 14 at proportional levels. E was de-
tected in fractions 8 to 10, where M and N proteins were also
enriched. Altogether, these results show that secreted viral
structural proteins cosediment in sucrose gradient and there-
fore strongly suggest that viral proteins are associated into
VLPs. Moreover, secretion of E-containing vesicles does not
seem to be a major phenomenon in Vero E6 cells expressing E
alone or in combination with other viral proteins in our system.
Indeed, in all conditions, levels of E in cell medium were
systematically low and only detected in fractions when coex-
pressed with M and N.
Altogether, these data establish for the first time that all
three M, E, and N structural SARS-CoV proteins are impor-
tant for the efficient production and release of SARS-CoV
VLPs.
S is incorporated onto SARS-CoV M-E-N-containing VLPs.
We then investigated whether the SARS-CoV S glycoprotein
could be incorporated onto secreted M-E-N VLPs. S cDNA
was codon optimized and subcloned in the pcDNA vector.
Vero E6 cells were transfected with pIRES-M-E plus pcDNA-
Nflag plus pcDNA-S. Protein expression was verified in cell
lysates at 48 h posttransfection (data not shown). To monitor
the association of S onto M-E-N VLPs, we performed sucrose
fractionation on VLPs previously purified from culture me-
dium (Fig. 2). All S, Nflag, M, and E proteins were cosedi-
mented and enriched in fractions 9 and 10 corresponding to
40% sucrose. It is notable that S was mainly detected in its
native trimeric form in these fractions (540 kDa), although we
also detected low levels of monomers (180 kDa) and dimers
(360 kDa), which may have resulted from sample treatment
and SDS-polyacrylamide gel electrophoresis conditions. Higher-
molecular-weight proteins, detected with anti-S antibodies,
were found in the lightest fractions 1 to 6. These forms could
correspond to soluble, nonincorporated forms of S proteins
that have formed aggregates. We have previously described the
formation of S aggregates in preparations of purified SARS-
CoV S trimers from mammalian cell lysates (31). This result
confirms the association of all four SARS-CoV structural pro-
teins into S-M-E-N VLPs that can be purified from the culture
medium of transfected cells.
VLPs bud into a perinuclear compartment and are trans-
ported within vesicles to the plasma membrane. We next stud-
ied the subcellular localization of SARS-CoV VLPs by elec-
tron microscopy (Fig. 3). pIRES-M-E plus pcDNA-Nflag plus
pcDNA-S cotransfected Vero E6 cells were fixed at 24 and 48 h
posttransfection, and ultrathin sections were prepared for
transmission electron microscopy (Fig. 3A to G). Large
amounts of VLPs, with diameters ranging from 40 to 150 nm
on the sections, were found within the cytoplasm of positive
cells. Three main patterns of subcellular localization were ob-
served. First, VLPs were found within perinuclear compart-
ments, which had an appearance of groups of vacuoles (Fig.
3A, C, and D) or, alternatively but seldom observed, which
presented morphological characteristics of the ER (Fig. 3B).
Vacuoles were observed at both 24 and 48 h posttransfection
with a diameter ranging from 300 nm to 1.5 m on the sections.
Very interestingly, we detected several events of VLP budding
at vacuole membranes (Fig. 3D). Although VLPs accumulated
therein, they were not highly compacted in this compartment.
Moreover, VLPs appeared pleiomorphic and heterogeneous
material was also observed (Fig. 3D). Tubular structures were
seen within some VLP-containing vacuoles, mainly at 24 h
posttransfection (data not shown). Second, VLPs were ob-
served in vesicles scattered in the cytoplasm (Fig. 3A, B, C, and
E). These vesicles had a diameter ranging from 200 nm to 1 m
on sections, and the VLPs were more compacted inside. They
could be found near the perinuclear VLP-containing compart-
ments up to the cortical area. VLPs contained in these vesicles
looked more homogeneous in size and shape. Third, VLPs
were occasionally found at the cell surface (Fig. 3A, F, and G).
Although we could not observe obvious spikelike structures
surrounding the VLP envelope, spikelike protuberances were
occasionally detected (Fig. 3G). Moreover, binding of VLPs to
the cell surface suggests the presence of spikes and receptor
recognition. Some cells, in which very high amounts of VLPs
were found, presented characteristics of apoptosis with frag-
mented nucleus and disrupted membranes (data not shown).
The cytoplasm of these cells was filled up with VLPs, either
free or within intracellular compartments. The morphology of
released VLPs was investigated further by electron microscopy
on negatively stained particles that were purified from the cell
medium (Fig. 3F). Round particles with a diameter of 80 to 100
nm were readily observed. Again, we could not observe the
typical corona of spikes around VLPs (21), but globular struc-
tures protruding from VLPs were detected, which likely cor-
responded to trimers of the spikes. Altogether, our data sug-
gest that SARS-CoV VLPs bud in an intracellular
compartment of Vero E6 cells and are efficiently transported
within vesicles to the plasma membrane where they are re-
leased. The shapes and sizes of the secreted VLPs are in
accordance with the morphological characteristics of the
SARS-CoV, and therefore these VLPs should be a safe and
appropriate model for studying the assembly and release of
SARS-CoV virions.
FIG. 2. S-glycoprotein trimers are incorporated onto SARS-CoV
M, E, and N-containing VLPs. pcDNA-S plasmid was cotransfected
with pIRES-M-E and pcDNA-Nflag vectors. The culture medium was
harvested at 48 h posttransfection and ultracentrifuged on 20% su-
crose cushion, and the pellets were resuspended in TNE buffer and
ultracentrifuged on a 20 to 60% discontinuous sucrose gradient.
Twenty fractions were collected (1 to 20, from lightest to heaviest) and
analyzed by Western blotting. Samples were either heat denatured and
reduced with dithiothreitol before loading for detection of Nflag, M,
and E or not heated and not reduced for analysis of S. Blots were
exposed for 10 s for signal detection, except for E, for which the blots
were exposed for 10 min. The highest levels of S, M, N, and E struc-
tural proteins were found in fractions 9 and 10 corresponding to 40%
sucrose. S protein was detected with mouse polyclonal antibodies
raised against purified S trimers. Arrows indicate bands that corre-
spond to trimeric and monomeric forms of S. The molecular mass (in
kilodaltons) and the migration of protein standards are shown on the
right sides of the blots.
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FIG. 3. Structural analysis and intracellular distribution of SARS-CoV VLPs. Vero E6 cells were cotransfected with pIRES-M-E, pcDNA-Nflag, and
pcDNA-S. At 24 and 48 h posttransfection the cells were fixed, and ultrathin sections were analyzed by electron microscopy (A to G). (A) VLPs were found in
intracellular vacuoles (vc) and in vesicles (vs) scattered in the cytosol and bound to the plasma membrane (pm). The arrow points to VLPs attached to the cell
surface. (B) Large amount of VLPs within the lumen of the endoplasmic reticulum (er) and within a cytoplasmic vesicle. n, nucleus. (C) Presence of VLPs within
vacuoles and vesicles. Arrows point to small VLPs-containing vesicles beneath the plasma membrane. (D) Magnification of a VLP-containing vacuole. Black
arrows point to budding events. (E) Compacted VLP-containing vesicles were found beneath the plasma membrane. (F) VLPs bound to the surface of a
producer cell. Two membrane-bound VLPs are indicated by arrows. (G) VLPs bound to a cell filopodia. Spikelike protuberances were visible on the VLP surface
(arrows). (H) Electron microscopy images of negatively stained VLPs purified from cell medium at 48 h posttransfection. A scale bar is indicated for each picture.
Panels A to D and panels F to G correspond to cells fixed at 48 h posttransfection. The image in panel E was taken from cells fixed at 24 h posttransfection.
n, nucleus; er, ER; vc, vacuole; vs, vesicle; pm, plasma membrane.
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Assembly and release of VLPs that incorporate fluorescently
tagged structural viral proteins. In order to visualize in real
time the assembly, trafficking, and release of SARS-CoV
VLPs, we engineered plasmid constructs that allow expression
of viral proteins in fusion with fluorescent proteins. The
pIRES-MmRFP1-E, pcDNA-NeCFP, and pcDNA-SeYFP
constructs were developed, and the expression of fusion viral
proteins was analyzed in individually transfected or cotrans-
fected cells by fluorescence microscopy (Fig. 4). We did not
include any construct coding for a fluorescently tagged SARS-
CoV E protein because it does not tolerate fluorescent protein
tags (C. Chan et al., unpublished data). All chimeric viral
proteins could be readily observed by fluorescence microscopy.
In cells individually transfected with the pIRES-MmRFP1-E,
the MmRFP1 fusion protein was mainly present in a perinu-
clear compartment, most likely the ERGIC/Golgi apparatus
(Fig. 4a and b). We also found MmRFP1 within the cytoplasm
and occasionally at the plasma membrane. As expected, the
SeYFP protein was observed both in the ERGIC/Golgi appa-
ratus and at the plasma membrane of individually transfected
cells (Fig. 4c and d). These expression patterns are similar to
what we observed previously for MeGFP and SeGFP fusion
proteins at 15 h postinfection with Semliki Forest virus expres-
sion vectors (51). In most of the cells, individually expressed
NeCFP protein formed bright cytosolic patches, suggesting
aggregation of the protein in the cytosol in the absence of
functional viral protein partners (Fig. 4e and f). This pattern
may reflect large inclusions of nucleocapsids, which have been
described to accumulate late in the infection of cells with
HCoV and MHV-JHM and SARS-CoV (6, 17, 23) or may
constitute a cytosolic reservoir of protein supposed to feed the
viral budding system. Interestingly, when plasmids were co-
transfected, all three MmRFP1, SeYFP, and NeCFP fluores-
cent proteins presented similar intracellular distributions, co-
localizing in the cytoplasm and at the plasma membrane (Fig.
4g, i, k, and m and Fig. 4h, j, l, and n). When coexpressed with
MmRFP1, E, and SeYFP, the subcellular distribution of the
NeCFP protein was dramatically changed, and bright cytosolic
patches were rarely found (Fig. 4e and f and Fig. 4k and l).
Trafficking of NeCFP to the cell surface in cotransfected cells
suggests that interactions with other viral proteins have oc-
curred, leading to NeCFP translocation. Nevertheless, no
VLPs were detected in medium from cotransfected cells (data
not shown). Altogether, these results suggest that although
MmRFP1, SeYFP, NeCFP, and E are likely to interact when
coexpressed in Vero E6 cells, they are not released in the form
of VLPs in cell medium.
We then reasoned that fluorescent VLPs could be produced
by including only one plasmid coding for one of the fluores-
cently tagged viral protein per cotransfection. In these condi-
tions, we investigated protein expression and release of VLPs
by Vero E6 cells at 48 h posttransfection (Fig. 5A). As a
positive control, we monitored VLP release from pIRES-M-E,
pcDNA-Nflag, pcDNA-S transfected cells. As expected, S,
Nflag, M, and E proteins were detected in both the cell lysate
and the VLP preparation (Fig. 5A, lanes 2 and 7). Although
the MmRFP1 fusion protein was readily observed by fluores-
cence microscopy, it could not be detected by Western blotting.
Most likely, the rabbit polyclonal antibody directed against the
M C-terminal domain cannot recognize its epitope when it is
fused to the mRFP1 fluorescent tag. Although the E, Nflag and
S proteins were detected on the cell lysate from pIRES-
MmRFP1-E plus pcDNA-Nflag plus pcDNA-S transfected
cells (Fig. 5A, lane 3), no protein corresponding to purified
VLPs was found in the medium (Fig. 5A, lane 8). We con-
cluded that fusion of the mRFP1 protein at the C-terminal end
of M inhibits VLP production. On the contrary, both pIRES-
M-E plus pcDNA-NeCFP plus pcDNA-S, as well as pIRES-
M-E plus pcDNA-Nflag plus pcDNA-SeYFP transfected cells
were able to release VLPs in cell medium, as indicated by the
presence of viral proteins (Fig. 5A, lanes 9 and 10). Under
these conditions, the NeCFP protein was detected by a mouse
monoclonal antibody directed against N (56) and migrated to
an apparent molecular size of 70 kDa.
To confirm that NeCFP or SeYFP viral proteins are cor-
rectly incorporated into VLPs, we analyzed purified VLPs by
fractionation on a 20 to 60% sucrose gradient (Fig. 5B). Both
NeCFP and SeYFP cosedimented with other viral proteins,
indicating that they were incorporated in purified VLPs (Fig.
5B, upper and lower panels, respectively). M-E-NeCFP-S
VLPs were concentrated in fractions 10 and 11. The E protein
was not detected, most likely because M-E-NeCFP-S VLPs
were less abundant in culture medium than M-E-Nflag-S VLPs
for which the E levels were already low. M-E-Nflag-SeYFP
VLPs were more efficiently produced and concentrated in frac-
tions 9 and 10, although high levels were also found in fractions
6, 7, and 8. Considering the high levels of M and Nflag detected
in these fractions, incorporation of SeYFP seems less efficient
than S (cf. Fig. 2 with Fig. 5B, lower panel). Altogether, our
FIG. 4. Expression and subcellular distribution of viral structural
proteins tagged with fluorescent proteins. Vero E6 cells grown on glass
coverslips were either transfected with single plasmids (left panels) or
cotransfected (right panels) with the three plasmids encoding the
MmRFP1, E, SeYFP, and NeCFP proteins. At 24 h posttransfection,
cells were processed for nuclear staining with DAPI dye, fixed, and
analyzed under a fluorescence microscope equipped with an ApoTome
device to acquire images of optical sections. a, b, g, and h, MmRFP1;
c, d, i, and j, SeYFP; e, f, k, and l, NeCFP; m and n, merged images.
For all conditions, two representative images are shown side by side.
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results demonstrate that fluorescent VLPs can be readily pro-
duced in Vero E6 transfected cells by incorporating either a
tagged N or S fusion protein.
Visualization of M-E-NeC/GFP-S VLP production and
transport in living Vero E6 cells. We then investigated the
formation and transport of fluorescent SARS-CoV VLPs in
living transfected cells by fluorescence microscopy. Knowing
that S is expressed all along the secretory pathway in both
singly transfected and cotransfected cells, we reasoned that N
would be a better marker for monitoring of SARS-CoV VLP
assembly. Furthermore, having demonstrated that M, E, and N
are the crucial factors for the assembly and egress of SARS-
CoV VLPs and anticipating that S-bearing VLPs could be
internalized back into producer cells by ACE-2-driven endo-
cytosis, we decided to omit S. Therefore, the pcDNA-NeCFP
plasmid was either transfected alone or cotransfected with
pIRES-M-E. Vero E6 cells were analyzed at 24 h posttrans-
fection. In most pcDNA-NeCFP transfected cells, eCFP sig-
nals were very bright and concentrated in large aggregates in
the cytosol at the periphery of the nucleus (Fig.6Aa). Inversely
and very interestingly, a different pattern was observed in most
of cells cotransfected with pIRES-M-E and pcDNA-NeCFP.
In these cells, eCFP fluorescence was more diffuse in the cell
cytosol: medium-size bright vesicles were concentrated in close
proximity to the nucleus, smaller and dimmer vesicles were
scattered in the cytoplasm, and occasionally bright dots were
enriched at the cell cortical area (Fig.6Ab). A few bright dots
were also found outside the cells in the surrounding medium.
This difference in NeCFP distribution pattern suggests that
NeCFP assembles with coexpressed M and E viral proteins to
form VLPs and traffics from the perinuclear assembly com-
partment to the cell surface, where fluorescent VLPs are
released into the medium.
We then further analyzed the trafficking dynamics of a fluo-
rescently tagged N protein, coexpressed with M and E enve-
lope proteins in living Vero E6 cells. Images were acquired by
using a spinning disc confocal microscope coupled to a charge-
coupled device camera suitable for high-speed and high-reso-
lution imaging. In these experiments we replaced the NeCFP
by a NeGFP fusion protein, which is excitable by the argon
laser the microscope was equipped with. We could consistently
identify three types of NeGFP containing vesicles, where flu-
orescent signal intensities, sizes, and movements differ (Fig.
6B; corresponding videos are provided in the supplemental
material). First, the largest and brightest vesicles were found
close to the nucleus and were static. Second, smaller and dim-
mer vesicles were trafficking actively, most of the time in a
multidirectional way, making transient interactions with other
vesicles. Occasionally, these vesicles moved in rapid, unidirec-
tional way and for longer distances, most likely along micro-
tubules. Third, some cells presented an accumulation of bright
dots at the cortical area, which may correspond to smaller
secretory vesicles and released VLPs. A few bright dots were
found outside cells, which probably correspond to fluorescent
VLPs that have been released from producer cells. These re-
sults illustrate that fusion of a fluorescent tag to the C-terminal
end of the nucleocapsid viral protein makes monitoring of
SARS-CoV VLPs’ egress possible.
We then investigated the effect of BFA, a fungal metabolite
that has multiple effects upon the organelles of the secretory
pathway, including inhibition of trafficking from ER to the
Golgi apparatus, fusion of the cisternae of the Golgi with the
ER, and fusion of the trans-Golgi network with endosomes
(59). BFA has been used in previous studies for analysis of viral
protein transport and virus assembly (10, 49). Time-lapse im-
ages of living Vero E6 cells transfected with M-E plus NeGFP
were acquired at 24 h posttransfection (Fig. 6C; for a video, see
the supplemental material). In a first time, cells were either not
treated (Fig.6Ca) or treated with 6 g of BFA/ml for 4 h
(Fig.6Cd) or overnight (Fig.6Cg). After several minutes of
acquisition in these conditions, medium was changed to either
BFA-containing medium (Fig. 6Cb and c) or normal medium
FIG. 5. Production of fluorescent VLPs by transfected Vero E6
cells. (A) Determination of optimal plasmid combinations for produc-
tion of SARS-CoV fluorescent VLPs. Viral proteins from cell lysates
(left panel) and sedimented VLPs from medium (right panel) were
analyzed by Western blotting. VLPs could be produced when either N
or S (lanes 9 and 10) but not M (lane 8) were tagged with fluorescent
proteins. (B) Production of fluorescent VLPs and efficiency of incor-
poration of NeCFP and SeYFP fusion proteins into VLPs. Cells were
cotransfected with the specified plasmid combinations (corresponding
to lanes 9 and 10 of panel A), and purified VLPs from medium were
analyzed by using a sucrose gradient. Tagging S (lower blot) resulted in
a greater yield of VLP production compared to tagged N (upper blot).
However, the eYFP tag greatly reduced S incorporation into VLPs
(lower blot). Arrowheads indicate spike trimers and monomers.
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FIG. 6. Tracking of fluorescent SARS-CoV VLPs in living cells. (A) Wide-field fluorescence microscopy images showing the accumulation of
fluorescent VLPs at the plasma membrane of pIRES-M-E plus pcDNA-NeCFP cotransfected cells (panel b), whereas a strong perinuclear staining
was observed in Vero E6 cells expressing NeCFP alone (panel a). (B) Confocal microscopy of living cells expressing M-E-NeGFP VLPs. Four
categories of fluorescent signals were observed: a bright and static large perinuclear compartment (white encircling lines), smaller and dimmer
actively trafficking vesicles (orange encircling lines), bright dots accumulating at the cell cortex (yellow encircling lines), and dots in the medium
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(Fig. 6Ce and f and Fig. 6Ch and i), respectively. New se-
quences of images were acquired, and the fluorescence redis-
tribution was analyzed. Upon BFA treatment we observed
fusion of scattered fluorescent vesicles into large cytosolic flu-
orescent clusters accumulating at the center of the cell and
diminution of puncta (Fig. 6Ca, b and c and see also the
supplemental material). After treatment of cells for 4 h with
BFA, most of the fluorescence was present in large bright
patches surrounding the nucleus (Fig. 6Cd). Vesicles could still
be observed in the cytosol, although they were less numerous
than in nontreated cells. After a BFA wash step, we could not
observe any obvious reversibility of the massive redistribution
of fluorescence (compare Fig. 6Cd and e and Fig. 6Cf). After
overnight incubation with BFA, fluorescence was associated
with large cytosolic clusters and ER (Fig. 6Cg), and no drastic
change was observed after the BFA wash and recovery for 1 h
30 min (Fig. 6Ch), although membrane dynamics seem to in-
crease at the edge on the reticular compartment, where tubules
were elongated (Fig. 6Ch; see also the supplemental material).
A 3-h recovery period after overnight BFA treatment partially
restored trafficking of fluorescent vesicles in transfected cells
(Fig. 6Ci). The recovery process after BFA treatment was slow,
and the dynamics could not be followed for several hours,
because repetitive exposure to laser induced apoptosis. Al-
together, our results suggest (i) that BFA induces reorganiza-
tion of NeGFP-associated compartments and alters vesicle for-
mation and transport and (ii) that a period of several hours of
recovery after a BFA washing step is necessary in order to
restore the dynamics of the NeGFP-associated compartment
and vesicle trafficking. Further studies are needed in order to
clarify what subcellular compartment VLPs are associated with
and delineate the dynamics of egress in association with cellu-
lar structures.
DISCUSSION
The minimal molecular requirement for efficient assembly
and egress of SARS-CoV virions is still controversial. We de-
scribe here the development of a plasmid-based transfection
method for the efficient production and release of SARS-CoV
VLPs in permissive Vero E6 green monkey kidney epithelial
cells. In contrast to reports on other coronaviruses, we dem-
onstrate that all three M, E, and N SARS-CoV structural
proteins are required for the efficient assembly and release of
VLPs by transfected cells. When the S viral envelope glyco-
protein is coexpressed with M, N, and E, trimers of S are
incorporated into VLPs. Of particular interest is the finding
that incorporation of a fluorescently tagged N protein into
VLPs allows visualization of transport of de novo formed par-
ticles in producer cells. Fluorescent VLPs constitute a new
powerful model for studying the mechanisms of SARS-CoV
egress in living cells and the specific roles of cellular machin-
eries by fluorescence imaging techniques.
Other research groups have described the formation of
SARS-CoV VLPs in either insect (26, 44, 50) or mammalian
(27–29) cells, using various expression systems. Y. Huang et al.
were the first to report the generation of SARS-CoV VLPs in
human 293 renal epithelial cells (29). Human codon optimized
genes encoding for M, E, N, and S proteins were subcloned
into mammalian expression vector, and VLP formation was
monitored by transmission electron microscopy on transfected
cells at 63 h posttransfection. These authors show that, in their
experimental conditions, M and N are necessary and sufficient
for the formation of intracellular VLPs, independently of E
and S, but the secretion of VLPs was not efficient. Moreover,
they described S as being an important viral factor for the
maturation and egress of VLPs from cells, but the release of
M-N-S VLPs in culture medium was still inefficient. In con-
trast, in our system we detected sedimentable M and N pro-
teins in culture medium from M- plus N-expressing cells, sug-
gesting that M-N VLPs can form and be secreted (Fig. 1).
Furthermore, the coexpression of E greatly boosted the levels
of VLPs detected in the culture medium (Fig. 1), and the
addition of S did not influence the rate of VLP production
(Fig. 2 and data not shown). In contrast, Hsieh et al. (27) have
shown that coexpressed E and M proteins are released 4 days
posttransfection in culture medium of Vero E6 cells in the
absence of S and N proteins. In that study, Vero E6 cells,
previously infected with a recombinant vaccinia virus harbor-
ing the T7 polymerase gene, were cotransfected with plasmids
encoding MycHis or V5His-tagged S, M, E, and N structural
proteins. Nevertheless, sedimentable E and M proteins were
also found in the culture medium even when they were indi-
vidually expressed, and very high amounts of E were found in
VLP preparations in comparison to other viral proteins, sug-
gesting the formation of E-containing vesicles. Others have
shown that MHV and infectious bronchitis virus E protein
expressed alone results in the assembly of E-protein-contain-
ing vesicles, with a density similar to that of VLPs (7, 47). We
also found sedimentable SARS-CoV E proteins in culture me-
dium from individually pcDNA-E transfected cells, suggesting
the secretion of E vesicles, but we could not detect them in any
fraction after sucrose gradient fractionation, suggesting a low
production rate (Fig. 1). We could also detect M-E VLPs at
48 h posttransfection by coexpressing both E and M proteins,
albeit at very low levels (Fig. 1). In our study, we took advan-
tage of the pIRES bicistronic vector to ensure the concomitant
expression of E and M and to maintain a low expression level
for E. We show that the use of this vector system, in combi-
nation with the expression of N, ensures slightly better levels of
M-E-N VLPs in the medium and great incorporation of E (Fig.
1B). Higher levels of E were expressed when an individual
surrounding transfected cells (yellow dots). Videos are available in the supplemental material. (C) Treatment of transfected cells with BFA alters
the trafficking of fluorescent vesicles. Vero E6 cells were transfected with pIRES-M-E plus pcDNA-NeGFP plasmids. Cells were either not treated
(panel a) or treated with 6 g of BFA/ml for either 4 h (panel d) or overnight (panel g). BFA was then added to untreated cells, and time-lapse
acquisitions were performed. Panels b and c show the same cells as in panel a but after 25- and 70-min incubations with the drug. Alternatively,
BFA was washed out and recovery after BFA treatment was analyzed (panels e and f and panels h and i). Panels a, b, and c, panels d and e, and
panels g and h show the same cells at different time points. Videos illustrating panels b, f, h, and i are provided in the supplemental material.
VOL. 82, 2008 M, E, AND N STRUCTURAL PROTEINS OF SARS 11327
 o
n
 August 18, 2014 by BRUNEL UNIV SERVICES LTD
http://jvi.asm.org/
D
ow
nloaded from
 
pcDNA-E vector was used for E expression and resulted in
increased E/M and E/N ratios in the cell medium (Fig. 1B). We
could not conclude whether this was due to a higher level of E
incorporation into VLPs or to a simultaneous release of E-
containing vesicles and VLPs. Analysis of viral protein in cell
medium by sucrose gradient fractionation revealed that E was
only released at significant levels when coexpressed with M and
N proteins, with which it cosediments (Fig. 1Cb, c, and e). We
have observed efficient M-E-N-S VLP formation and release in
293T, HeLa, and Huh-7 human cell lines (data not shown).
Consistently, the formation and release of M-E-N-S VLPs
from 293T cells has been shown in another study reported by
C. Huang et al., in which the authors used a pCAGGS mam-
malian expression plasmid-based transfection system (28).
Lokugamage and coworkers were able to generate approxi-
mately 1.3 g of SARS-CoV VLPs from 2  107 293T cells
(42). Recently, we have measured the quantity of S incorpo-
rated into the envelopes of M-E-N-S VLPs purified from the
VLP-containing sucrose fractions in our system. Approxi-
mately 1 and 28 g of S were present in VLP preparations
from 107 VeroE6 and 293T cells, respectively (data not
shown).
We also investigated the formation and secretion of SARS-
CoV VLPs in transfected cells by transmission electron micros-
copy and negative staining of purified secreted particles (Fig.
3). We were able to identify budding events in cytoplasmic
perinuclear compartments. VLP-containing vesicles were scat-
tered within the cytoplasm and found beneath the plasma
membrane. Occasionally, secreted VLPs were bound to the
cell surface. The VLP-associated compartments that we ob-
served in transfected Vero E6 cells share significant similarities
with the virion-containing compartments described in SARS-
CoV-infected Vero E6 cells at 3 to 5 days postinfection (23).
VLPs were readily detected in sedimented fractions from cul-
ture medium by negative staining and electron microscopy
(Fig. 3H). Globular structures protruding from the VLP enve-
lope, and which should correspond to spike peplomers, were
occasionally detected, but we could not identify any particle
displaying a typical corona-like structure which is the signature
of the optimal incorporation of spike trimers on the virion
envelope.
Interestingly, we found that a C-terminal Flag or eYFP tag
affects the levels of S trimers incorporation into VLPs (data
not shown or Fig. 5, respectively). However, Sflag and SeYFP
proteins could still be incorporated into VLPs, and tags can be
used as markers. Similar results had been obtained for MHV,
where the S sequence had been extended by fusion with a GFP
fluorescent protein (3). These data can be explained by several
factors: the 30-kDa fluorescent protein may cause geometrical
constraints; M-S interactions, which are important for S incor-
poration may be affected by the tag; and S retention to the site
of viral assembly may be disturbed (43, 48). We also tried to
produce VLPs containing the mRFP1 fluorescent protein
fused to the C-terminal end of M (Fig. 4 and 5A). Although
MmRFP1 was expressed in transfected cells, the production of
VLPs was abrogated. The M endodomain is crucial for M-N,
M-E, and M-S interactions and VLP formation (8, 13, 15, 19),
and its fusion to a fluorescent protein tag may affect its struc-
ture and/or availability for interaction with other partners. This
hypothesis is reinforced by the complete loss of recognition of
the chimeric MmRFP1 by a rabbit serum raised against a
C-terminal peptide of M (Fig. 5A, left panel).
Lastly, a fusion NeCFP protein could be expressed and as-
semble into VLPs with M, E, and S, although the levels of
VLPs detected in culture medium were significantly reduced
(Fig. 5). Interestingly, whereas individually expressed NeCFP
or NeGFP were found in the cell cytosol, often accumulating in
the perinuclear area, the tagged N protein had a tendency to
display a vesicular distribution pattern when coexpressed with
M and E (Fig. 6). We analyzed both the distribution and the
trafficking of the NeGFP protein in transfected live cells by
confocal microscopy (Fig. 6B). When cells were cotransfected
with pIRES-M-E and pcDNA-NeGFP, the NeGFP proteins
were often found in a static compartment near the nucleus, in
trafficking vesicles scattered in the cytosol and moving actively,
making transient interactions with other vesicles, and as small
dots scattered in the cortical area beneath the plasma mem-
brane, often enriched in cell projections. Fluorescent dots were
also detected in the cell medium surrounding living cells. A
subcellular distribution of NeGFP is consistent with our trans-
mission electron microscopy data. Most likely, the perinuclear
static compartments and trafficking vesicles identified by fluo-
rescence microscopy correspond to perinuclear vacuoles,
membranes where VLP budding events were observed, and to
VLP-containing vesicles found by electron microscopy, respec-
tively. The fluorescent dots observed in the cell cortical area
may correspond to smaller secretory vesicles containing fewer
VLPs—vesicles containing only one VLP were found by elec-
tron microscopy—and/or to released VLPs, which are bound
to the cell surface. Interestingly, the transport of fluorescent
vesicles was affected by the drug BFA, which is well known to
affect membrane transport in the secretory pathway (39, 59).
BFA treatment induced backward trafficking of fluorescent
vesicles and fusion into bright perinuclear clusters (Fig. 6Ca, b,
and c). Long-lasting BFA treatment resulted in the suppres-
sion of vesicle trafficking, no fluorescent puncta were found at
plasma membrane (Fig.6Cg), and recovery of vesicle trafficking
was restored after several hours in normal medium (Fig.6Ci).
Altogether, our data demonstrate that M, E, and N struc-
tural proteins are key molecules in the assembly and egress of
the SARS-CoV. Production and analysis of fluorescent M-E-
NeGFP SARS-CoV VLPs in living cells allowed us to identify
three subcellular structures with different velocity characteris-
tics along the secretory pathway. Molecular and cellular deter-
minants of SARS-CoV assembly and egress will be investigated
further using advanced fluorescence microscopy techniques.
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